Authors: Bodner, K Bodner-Adler, B Obermair, A Windbichler, G Petru, E Mayerhofer, S Czerwenka, K Leodolter, S Kainz, C Mayerhofer, K

Citation: K. Bodner et al., Prognostic parameters in endometrial stromal sarcoma: A clinicopathologic study in 31 patients, GYNECOL ONC, 81(2), 2001, pp. 160-165

Authors: Obermair, A Petru, E Windbichler, G Peters-Engl, C Graf, AH Stummvoll, W Kaider, A Kurschel, S Kolbl, H Sevelda, P

Citation: A. Obermair et al., Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer, ONCOL REP, 7(3), 2000, pp. 639-644

Authors: Abendstein, B Daxenbichler, G Windbichler, G Zeimet, AG Geurts, A Sweep, F Marth, C

Citation: B. Abendstein et al., Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients, ANTICANC R, 20(1B), 2000, pp. 569-572

Authors: Mayerhofer, K Obermair, A Windbichler, G Petru, E Kaider, A Hefler, L Czerwenka, K Leodolter, S Kainz, C

Citation: K. Mayerhofer et al., Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases, GYNECOL ONC, 74(2), 1999, pp. 196-201

Authors: Marth, C Windbichler, G Zeimet, AG Daxenbichler, G Graf, A Stummvoll, W Fuchs, D

Citation: C. Marth et al., Activated immune system in associated with poor prognosis in ovarian cancer, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 247-251